Eleven Biotherapeutics Adds Biotech Industry Veterans To Management Team And Board
Published: Jan 02, 2014
Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the appointment of Gregory D. Perry as Chief Financial and Business Officer, Daniel S. Lynch as Chairman of the company’s board of directors and Jane Pritchett Henderson as a member of the board of directors.
Help employers find you! Check out all the jobs and post your resume.